American Bio Medica Receives Patent for Its 9 Panel Rapid Drug Screen.Business/Health Editors KINDERHOOK, N.Y.--(BUSINESS WIRE)--Sept. 6, 2000 American Bio Medica medica (māˑ·dē·k Corp. (Nasdaq:ABMC ABMC American Battle Monuments Commission ABMC Alexian Brothers Medical Center (Illinois) ABMC Aviation Battle Management Concept ABMC Arrowbear Music Camp (California) ), which develops, manufactures and markets drugs-of-abuse diagnostic kits, sprays and support services, today announced that the U.S. Patent and Trademark Office has issued a design patent for the Company's 9 panel Rapid Drug Screen(TM). The Rapid Drug Screen is a simple, inexpensive onsite test that detects the presence or absence of drugs of abuse in urine. The 9 panel Rapid Drug Screen simultaneously detects THC THC tetrahydrocannabinol. THC n. Tetrahydrocannabinol; a compound that is obtained from cannabis or is made synthetically; it is the primary intoxicant in marijuana and hashish. , cocaine, opiates, PCP PCP abbr. 1. phencyclidine 2. primary care physician Pneumocystis carinii pneumonia (PCP) , amphetamines, benzodiazepines Benzodiazepines Definition Benzodiazepines are medicines that help relieve nervousness, tension, and other symptoms by slowing the central nervous system. Purpose Benzodiazepines are a type of antianxiety drugs. , methamphetamines, barbiturates Barbiturates Definition Barbiturates are medicines that act on the central nervous system and cause drowsiness and can control seizures. Purpose , and tricyclic antidepressants. The 9 panel test is marketed in the clinical sector for use in hospitals, physician offices and occupational health centers. ABMC Chairman and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. Stan Cipkowski stated, "We are pleased to have yet another addition to our expanding portfolio of patents and trademarks worldwide. We continue to secure our position in the market by protecting our intellectual property rights." Cipkowski added, "The 9 panel Rapid Drug Screen is critical to our success in the clinical sector, a market which we know will have a significant positive impact on our sales growth. We are one of very few companies who can deliver the test for tricyclic antidepressants and now that product is protected. The successful development of this test demonstrates our technical team's ability to meet the industry's most demanding scientific challenges." American Bio Medica Corporation develops, manufactures and markets inexpensive, accurate on-site drugs-of-abuse diagnostic kits, sprays and support services worldwide. The company's global distributors target the workplace, physicians, corrections, clinical and educational markets. ABMC's Drug Detector(TM) identifies minute traces of illegal drugs on surfaces, while the company's Rapid Drug Screen tests individuals and is proven to correlate 100% with the standard laboratory screening test. Forward-looking statements in this release are made pursuant to the "safe harbor" provisions of the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995. Investors are cautioned that such forward-looking statements involve risk and uncertainties, including without limitation, continued acceptance of the Company's products, increased levels of competition for the Company, new products and technological changes, the Company's dependence on third-party suppliers, intellectual property rights and other risks detailed from time to time in the Company's periodic reports filed with the Securities and Exchange Commission. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion